704 Participants Needed

Quality of Life After Treatment for Bladder Cancer

Recruiting at 2 trial locations
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines how bladder cancer treatments affect quality of life. Participants will complete surveys and allow researchers to review their medical records to assess the impact of treatments such as surgery or radiation. The goal is to understand how these treatments influence daily living and well-being. Individuals recently diagnosed with localized bladder cancer and about to begin treatment may be suitable for this study. As a Phase 2 trial, the research focuses on evaluating the treatment's effectiveness in an initial, smaller group, providing participants an opportunity to contribute to significant findings.

Do I need to stop my current medications for this bladder cancer trial?

The trial information does not specify whether you need to stop taking your current medications.

Why are researchers excited about this trial?

Researchers are excited about this trial because it focuses on understanding the quality of life for bladder cancer survivors, something not typically addressed by standard treatments like surgery, chemotherapy, or immunotherapy. Unlike traditional treatments that mainly aim to remove or kill cancer cells, this trial looks at the long-term well-being and daily experiences of patients after treatment. By reviewing medical records and collecting patient surveys, researchers hope to uncover insights that can lead to improved support and care strategies for survivors, ultimately enhancing their overall quality of life.

Who Is on the Research Team?

MD

Mark D. Tyson, M.D., M.P.H.

Principal Investigator

Mayo Clinic

Are You a Good Fit for This Trial?

Inclusion Criteria

I am capable of understanding and agreeing to the study's procedures.
My bladder cancer is confirmed and has not spread beyond the bladder.
I am willing to fill out a survey in English before starting my main cancer treatment.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Observational

Patients complete surveys and have their medical records reviewed to assess quality of life outcomes

36 months

Follow-up

Participants are monitored for quality of life outcomes at multiple intervals after treatment

36 months

What Are the Treatments Tested in This Trial?

Interventions

  • Non-Interventional Study

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: ObservationalExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+